Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NATIONAL RESEARCH CORP Director's Dealing 2013

Jul 2, 2013

33341_dirs_2013-07-02_581337cc-d53d-41d9-88fc-e78a698eb0a7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NATIONAL RESEARCH CORP (NRCIA/B)
CIK: 0000070487
Period of Report: 2013-06-28

Reporting Person: Hays Michael D. (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-06-28 Class A Common Stock S 13153 $18 Disposed 5823147 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 375750 Indirect
Class A Common Stock 75 Indirect
Class B Common Stock 1806050 Direct
Class B Common Stock 62625 Indirect
Class B Common Stock 12 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (right to buy) $4.81 2014-01-05 Class A Common Stock (54894) 54894 Direct
Employee Stock Option (right to buy) $5.12 2016-01-05 Class A Common Stock (33234) 33234 Direct
Employee Stock Option (right to buy) $6.62 2017-01-05 Class A Common Stock (25068) 25068 Direct
Employee Stock Option (right to buy) $7.59 2018-01-04 Class A Common Stock (21633) 21633 Direct
Employee Stock Option (right to buy) $8.12 2019-01-05 Class A Common Stock (20109) 20109 Direct
Employee Stock Option (right to buy) $6.29 2020-01-05 Class A Common Stock (26481) 26481 Direct
Employee Stock Option (right to buy) $9.14 2021-01-05 Class A Common Stock (17745) 17745 Direct
Employee Stock Option (right to buy) $10.75 2022-01-05 Class A Common Stock (14949) 14949 Direct
Employee Stock Option (right to buy) $14.50 2023-01-07 Class A Common Stock (10938) 10938 Direct
Employee Stock Option (right to buy) $12.6 2014-01-05 Class B Common Stock (9149) 9149 Direct
Employee Stock Option (right to buy) $13.06 2016-01-05 Class B Common Stock (5539) 5539 Direct
Employee Stock Option (right to buy) $15.31 2017-01-05 Class B Common Stock (4178) 4178 Direct
Employee Stock Option (right to buy) $16.76 2018-01-04 Class B Common Stock (3605) 3605 Direct
Employee Stock Option (right to buy) $17.57 2019-01-05 Class B Common Stock (3351) 3351 Direct
Employee Stock Option (right to buy) $14.82 2020-01-05 Class B Common Stock (4413) 4413 Direct
Employee Stock Option (right to buy) $19.09 2021-01-05 Class B Common Stock (2957) 2957 Direct
Employee Stock Option (right to buy) $21.5 2022-01-05 Class B Common Stock (2491) 2491 Direct
Employee Stock Option (right to buy) $27.13 2023-01-07 Class B Common Stock (1823) 1823 Direct

Footnotes

F1: Does not include 375,000 shares of class A common stock currently held in a certain GRAT agreement, all or a portion of which will be returned to Mr. Hays over the next two years.

F2: Does not include 375,000 shares of class A common stock currently held in a certain GRAT agreement, all or a portion of which will be returned to Mr. Hays' spouse over the next two years.

F3: The reporting person disclaims beneficial ownership of these shares.

F4: Does not include 62,500 shares of class B common stock currently held in a certain GRAT agreement, all or a portion of which will be returned to Mr. Hays over the next two years.

F5: Does not include 62,500 shares of class b common stock currently held in a certain GRAT agreement, all or a portion of which will be returned to Mr. Hays' spouse over the next two years.

F6: On May 22, 2013, the Issuer completed a recapitalization pursuant to which it, among other things, issued a stock dividend of three shares of class A common stock for each share of then-existing common stock and reclassified each share of its then-existing common stock as one-half of one share of class B common stock. All fractional shares of class B common stock were cashed-out in the recapitalization. In connection with the recapitalization, the exercise prices of outstanding options were equitably adjusted to prevent the dilution or enlargement of the benefits intended to be provided.

F7: This option became fully exercisable on January 5, 2009.

F8: This option became fully exercisable on January 5, 2011.

F9: This option became fully exercisable on January 5, 2012.

F10: This option became fully exercisable on January 4, 2013.

F11: This option becomes fully exercisable on January 5, 2014.

F12: This option becomes fully exercisable on January 5, 2015.

F13: This option becomes fully exercisable on January 5, 2016.

F14: This option becomes fully exercisable on January 5, 2017.

F15: This option becomes fully exercisable on January 7, 2018.